Literature DB >> 4623164

C1r deficiency: an inborn error associated with cutaneous and renal disease.

N K Day, H Geiger, R Stroud, M DeBracco, B Mancaido, D Windhorst, R A Good.   

Abstract

The studies of sera from two siblings with C1r deficiency are described. The brother (18 yr old) has shown clinical manifestations resembling lupus erythematosus for 5 yr, and the sister (24 yr old) has had arthralgia and recurrent episodes of rhinobronchitis since early childhood. Three siblings have died: one brother died at age 12 with symptoms similar to the disease of the male patient studied here, and two other siblings died in infancy, probably from infection. The low hemolytic C1 activity of the patients could be restored by the addition of purified C1r to their sera. Bactericidal activity and immune adherence were found to be impaired. When alternate pathways of the complement system were studied, both sera permitted activation of terminal components with endotoxin and cobra venom factor. These findings support the view that an alternate pathway for activation of the terminal portion of the complement cascade exists which does not utilize the conventional pathway operating through the usual early components.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4623164      PMCID: PMC292239          DOI: 10.1172/JCI106902

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence.

Authors:  K NISHIOKA
Journal:  J Immunol       Date:  1963-01       Impact factor: 5.422

2.  Quantitative studies on the bactericidal actions of serum and complement. I. A rapid photometric growth assay for bactericidal activity.

Authors:  L H MUSCHEL; H P TREFFERS
Journal:  J Immunol       Date:  1956-01       Impact factor: 5.422

3.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

4.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

5.  Decreased C'-1q protein concentration and agglutinating activity in agammaglobulinaemia syndromes: an inborn error reflected in the complement system.

Authors:  H Gewurz; R J Pickering; C L Christian; R Snyderman; S E Mergenhagen; R A Good
Journal:  Clin Exp Immunol       Date:  1968-06       Impact factor: 4.330

6.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

7.  Complement activity and inflammatory neutrophil exudation in man. Studies in patients with glomerulonephritis, essential hypocomplementemia and agammaglobulinemia.

Authors:  H Gewurz; A R Page; R J Pickering; R A Good
Journal:  Int Arch Allergy Appl Immunol       Date:  1967

8.  IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.

Authors:  J H MORSE; C L CHRISTIAN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

9.  Complement and complement-like activity in lower vertebrates and invertebrates.

Authors:  N K Day; H Gewurz; R Johannsen; J Finstad; R A Good
Journal:  J Exp Med       Date:  1970-11       Impact factor: 14.307

10.  Deficiency of C1r in human serum. Effects on the structure and function of macromolecular C1.

Authors:  R J Pickering; G B Naff; R M Stroud; R A Good; H Gewurz
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  23 in total

Review 1.  The genetic and molecular bases of monogenic disorders affecting proteolytic systems.

Authors:  I Richard
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  Biological mechanism analysis of acute renal allograft rejection: integrated of mRNA and microRNA expression profiles.

Authors:  Shi-Ming Huang; Xia Zhao; Xue-Mei Zhao; Xiao-Ying Wang; Shan-Shan Li; Yu-Hui Zhu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.

Authors:  R E Jordon; N K Day; W M Sams; R A Good
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

4.  A new complement-mediated cytolytic mechanism--the C1-bypass activation pathway.

Authors:  J E May; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

5.  Developmental aspects of complement components in the newborn. The presence of complement components and C3 proactivator (properdin factor B) in human colostrum.

Authors:  M Ballow; F Fang; R A Good; N K Day
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

6.  Complement activation in pemphigus vulgaris blister fluid.

Authors:  R E Jordan; N K Day; J R Luckasen; R A Good
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

7.  Inherited deficiency of the second component of complement. Rheumatic disease associations.

Authors:  D Glass; D Raum; D Gibson; J S Stillman; P H Schur
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  The association of respiratory infection, recurrent hematuria, and focal glomerulonephritis with activation of the complement system in the cold.

Authors:  N K Day; H Geiger; R McLean; J Resnick; A Michael; R A Good
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

9.  A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.

Authors:  B Wellek; W Opferkuch
Journal:  Clin Exp Immunol       Date:  1975-02       Impact factor: 4.330

10.  C2 deficiency. Development of lupus erythematosus.

Authors:  N K Day; H Geiger; R McLean; A Michael; R A Good
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.